Ibrutinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Ibrutinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ibrutinib included in the composition |
Prices in pharmacies |
| Imbruvica | 4850€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 67% Akalabrutinib
- 56% Imatinib
- 56% Paphencyl
- 53% Chlorethylaminouracil
- 53% Bosutinib
- 50% Lophenalac
- 50% Cytarabine
- 48% Fludarabine
- 47% Dasatinib
- 45% Rufocromomycin
- 41% Lorlatinib
- 39% Mercaptopurine
- 38% Asparaginase
- 36% Dipin
- 35% Venetoclax
- 35% Prodimin
- 33% Lipegfilgrastim
- 32% Nilotinib
- 32% Tioguanine
- 32% Nelarabine
- 31% Ixazomib
- 28% Pazopanib
- 28% Busulfan
- 26% Trametinib
- 26% Cabozantinib
- 25% Amsacrine
- 25% Nintedanib
- 25% Daunorubicin
- 24% Immunoglobulin human normal
- 24% Sorafenib
- 24% Abemaciclib
- 23% Lenograstim
- 23% Procarbazine
- 23% Pegaspargase
- 22% Palbociclib
- 22% Vindesine
- 22% Dibrospidium chloride
- 21% Febuxostat
- 21% Epoetin alfa
- 21% Idarubicin
- 21% Chlorambucil
- 21% Fotretamine
- 20% Regorafenib
- 20% Vandetanib
- 19% Hydroxycarbamide
- 19% Nitrosomethylurea
- 18% Osimertinib
- 18% Ribociklib
- 18% Obinutuzumab
- 18% Teniposide
Learn more about the selection of analogues
- The drug has «Ibrutinib» 51 analog by action, the most similar - Akalabrutinib .
- Medical online service has selected the best substitutes for Ibrutinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ibrutinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.